PsychedelicNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) to Host Webinar Delving into Psychedelics Landscape, Current and Emerging Therapeutics
Jun 2, 2022
Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” today announced that it will host a virtual Key Opinion Leader webinar from 11:00 a.m. to 12:00 p.m. ET on Thursday, June 9, 2022. The webinar will be moderated by Cybin’s Chief Executive Officer Doug Drysdale and will feature two leading experts for a discussion on the psychedelics landscape and current and emerging psychedelic-based therapeutics. Dr. John Krystal, the Robert L. McNeil, Jr., Professor of Translational Research; Professor of Psychiatry, Neuroscience and Psychology; Chair of the Department of Psychiatry at Yale University; and Chief of Psychiatry and Behavioral Health at Yale-New Haven Hospital, will be included in the discussion. Also featured will be Dr. David Nutt, DM, FRCP, FRCPsych, FMedSci, DLaws, the Edmund J. Safra Professor of Neuropsychopharmacology, Head Centre for Psychedelic Research in the Division of Brain Sciences, Imperial College London. Interested parties should visit https://ibn.fm/EkkdK to register for the event and access the webcast. In addition, the archived version of the webcast will be available on the company’s investor relations website.
To view the full press release, visit https://ibn.fm/eDVTh
About Cybin Inc.
Cybin is a leading ethical biopharmaceutical company working with a network of world-class partners and internationally recognized scientists on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues. Headquartered in Canada and founded in 2019, Cybin is operational in Canada, the United States, United Kingdom and Ireland. The company is focused on progressing Psychedelics to Therapeutics(TM) by engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders. For more information, visit the company’s website at www.Cybin.com.
NOTE TO INVESTORS: The latest news and updates relating to CYBN are available in the company’s newsroom at https://ibn.fm/CYBN
About PsychedelicNewsWire
PsychedelicNewsWire (PNW) is a specialized content distribution company that (1) aggregates and distributes news and information on the latest developments in all aspects and advances of psychedelics and their use, (2) creates PsychedelicNewsBreaks designed to quickly update investors on important industry news, (3) leverages a team of expert editors to enhance press releases for maximum impact, (4) assists companies with the management and optimization of social media across a range of platforms, and (5) delivers unparalleled corporate communication solutions. PNW stays abreast of the latest information and has established a reputation as the go to source for coverage of psychedelics, therapeutics and emerging market opportunities. Our team of seasoned journalists has a proven track record of helping both public and private companies gain traction with a wide audience of investors, consumers, media outlets and the general public by leveraging our expansive dissemination network of more than 5,000 key syndication outlets. PNW is committed to delivering improved visibility and brand recognition to companies operating in the emerging markets of psychedelics.
To receive instant SMS alerts, text “Groovy” to 21000 (U.S. Mobile Phones Only)
For more information please visit https://www.PsychedelicNewsWire.com
Please see full terms of use and disclaimers on the PsychedelicNewsWire website applicable to all content provided by PNW, wherever published or re-published: https://www.PsychedelicNewsWire.com/Disclaimer
Do you have questions or are you interested in working with PNW? Ask our Editor
PsychedelicNewsWire (PNW)
San Francisco, California
www.PsychedelicNewsWire.com
415.949.5050 Office
[email protected]
PsychedelicNewsWire is part of the InvestorBrandNetwork.
More News
![aritcles[0].caption](https://static.ffx.io/images/$zoom_0.5295%2C$multiply_0.7554%2C$ratio_1.777778%2C$width_1059%2C$x_0%2C$y_0/t_crop_custom/q_86%2Cf_auto/2f3b58da0575b1b926ce027ef6e37ca1efec693a)
Apple’s big question: will customers rush to buy its $3500 foldable phone?
The answer to the question on everyone’s lips is hugely important to Apple, now and in the future.
Philadelphia police receive false homicide tip from Anthropic AI model
Anthropic’s artificial intelligence model submitted a false homicide tip to the Philadelphia Police Department in July, the company disclosed on Friday. The AI firm said its Claude Haiku 4.5 model filled out a form on a website page soliciting the public's help to gather more information about unsolved homicide on July 18. The model submitted...
Kalshi investigating suspicious bets tied to White house press secretary pick: Report
Prediction market Kalshi has opened an investigation into suspicious bets related to President Trump’s selection of his next press secretary, The Wall Street Journal reported. The company said that it was looking into at least three trades placed on its platform shortly before news outlets began announcing the appointment of Katie Zacharia to the White...
‘I never gave consent’: The Australians being replaced with copies of themselves
High-flying executives from across the world jetted in to the AI inquiry but the most startling revelations came from ordinary Australians.
Southwest Airlines says 'brief' system outage affected boarding, checked bags
Southwest confirmed the news shortly after travelers began to report delays on Friday morning.
Turns out, Jeff Beck was lying to me. How did I miss the vital clue?
AI fakery made a fool of me but soon I’ll be too mad to notice.
How it all went right, and then so wrong, for Australia’s big AI hope
Firmus’ bankers claimed it had a “slowly, then suddenly” growth story. Instead, that was how its public listing unravelled.
White House on Trump purchasing SpaceX debt before space order: 'No conflicts of interest'
The White House said Friday there was no conflict of interest when President Trump's accounts bought more than $1 million in SpaceX debt two days before he signed an executive order on space transportation policy. The president's financial disclosure for August, published Thursday, shows Trump's accounts purchased between $1 million and $5 million in senior...
Flock offers voluntary separation packages to staff amid camera backlash
The automated license plate reader (ALPR) firm Flock Safety has offered employees voluntary separation packages ahead of its "next phase of growth," as the firm faces mounting scrutiny from communities and policymakers across the country. "Flock recently offered current employees a generous Voluntary Separation Program as part of our efforts to position the company for...
The FBI has seized tools used by Chinese hackers for cyber operations, officials say
LOS ANGELES (AP) — The FBI has seized scanning and phishing tools used by a group of hackers that officials say is associated with the Chinese government and is believed responsible for disruptive cyber operations in the United States and abroad, including against the power industry, academia and critical infrastructure. The seizure of the tools,...
Two tech outsiders tried to sell a $44b tech company. It didn’t work
Oliver Curtis’ comeback was meant to end with the biggest float since Telstra. It ended with bankers going to ground and a plan B in New York.
‘I never gave consent’: The Australians being replaced with copies of themselves
High-flying executives from across the world jetted in to the AI inquiry but the most startling revelations came from ordinary Australians.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.